跳至主要内容
临床试验/NCT04848441
NCT04848441Unknown不适用

Risk of COVID-19 Infection After Vaccination: A Nationwide Study Comparing BNT162b2, mRNA-1273 and ChAdOx1

Umeå University0 个研究点目标入组 2,000,000 人开始时间: 2021年5月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
2,000,000
主要终点
Incident COVID-19 infection

研究概览

简要总结

The purpose of this observational nationwide study is to evaluate the effects of three different COVID-19 vaccines for the outcome of different severities of incident COVID infection.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
0 Years 至 110 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Living in Sweden and vaccinated with BNT162b2, mRNA-1273 or ChAdOx1
  • All individuals with a previous COVID-19 infection
  • Controls matched 1:1 to the groups above

排除标准

  • 未提供

结局指标

主要结局

Incident COVID-19 infection

时间窗: Up to six months after vaccination

Four different severities: Being diagnosed, hospitalized, ICU-care and death within 30 days of diagnosis

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

相似试验